MYC Is a Regulator of Androgen Receptor Inhibition-Induced Metabolic Requirements in Prostate Cancer

Scientists comprehensively characterized the effects of androgen receptor blockade on prostate cancer metabolism using transcriptomics, metabolomics, and bioenergetics approaches.